Spero Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of SPRO for the last quarter is 7.82 M USD, and it's 29.95% higher compared to the previous quarter. The net income of Q3 24 is -17.15 M USD.